Sintx Technologies Stock Today

SINT Stock  USD 2.99  0.11  3.82%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

High

 
High
 
Low
SINTX Technologies is selling for under 2.99 as of the 20th of March 2025; that is 3.82 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.82. SINTX Technologies has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company has 2.79 M outstanding shares of which 20.03 K shares are at this time shorted by private and institutional investors with about 0.03 trading days to cover. More on SINTX Technologies

Moving against SINTX Stock

  0.43MGRM Monogram Orthopaedics TrendingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

SINTX Stock Highlights

CEO PresidentEric Olson
Old Names[Scotia Strategic International Equity ETF Portfolio, SINTOFARM SA BUCURESTI]
Business ConcentrationMedical Equipment, Medical Devices, Healthcare, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
SINTX Technologies (SINT) is traded on NASDAQ Exchange in USA. It is located in 1885 West 2100 South, Salt Lake City, UT, United States, 84119 and employs 43 people. SINTX Technologies is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.46 M. SINTX Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 2.79 M outstanding shares of which 20.03 K shares are at this time shorted by private and institutional investors with about 0.03 trading days to cover. SINTX Technologies currently holds about 4.78 M in cash with (14.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check SINTX Technologies Probability Of Bankruptcy
Ownership Allocation
About 98.38 % of SINTX Technologies outstanding shares are held by general public with 1.62 % by institutional holders.
Check SINTX Ownership Details

SINTX Technologies Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. SINTX Technologies market risk premium is the additional return an investor will receive from holding SINTX Technologies long position in a well-diversified portfolio.

SINTX Stock Against Markets

SINTX Technologies Corporate Management

Michael MarcroftVice MarketingProfile
Gregg HonigblumChief OfficerProfile
JD MBAPresident, ChairmanProfile
David OBrienChief OfficerProfile
Gina MossDirector OperationsProfile

Additional Tools for SINTX Stock Analysis

When running SINTX Technologies' price analysis, check to measure SINTX Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINTX Technologies is operating at the current time. Most of SINTX Technologies' value examination focuses on studying past and present price action to predict the probability of SINTX Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINTX Technologies' price. Additionally, you may evaluate how the addition of SINTX Technologies to your portfolios can decrease your overall portfolio volatility.